An increased neutrophil-to-lymphocyte ratio predicts poorer survival following recurrence for patients with breast cancer

  • Authors:
    • Toshiaki Iwase
    • Takafumi Sangai
    • Masahiro Sakakibara
    • Junta Sakakibara
    • Emi Ishigami
    • Shouko Hayama
    • Ayako Nakagawa
    • Takahito Masuda
    • Shunsuke Tabe
    • Takeshi Nagashima
  • View Affiliations

  • Published online on: December 5, 2016     https://doi.org/10.3892/mco.2016.1101
  • Pages: 266-270
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The aim of the present study was to evaluate the association between changes in the neutrophil‑to‑lymphocyte ratio and the survival rate, as well as tumor subtype, in recurrent breast cancer. Patients with recurrent breast cancer following surgery were included in this study. NLR was calculated and compared between two time points: Pre‑treatment and recurrence. The associations between the longitudinal NLR change, the NLR at the time of recurrence and overall survival following recurrence (OSrec) were evaluated. A total of 89 patients were evaluated. NLR increased by 0.59 at recurrence, as compared with the initial treatment (P<0.05). The triple negative (TN) type demonstrated 4.59 in NLR, which was the highest among the four subtypes at the time of recurrence (P<0.05). The highest change (an increase of 2.0) was observed in TN type cancer (P<0.05). Patients with high NLR upon recurrence demonstrated significantly shorter OSrec rates (P<0.05). On the other hand, patients with an NLR increased by more than a third quartile demonstrated a shorter OSrec rate (P=0.06). When adjusted by covariates, the NLR and tumor subtype were determined to be associated with OSrec (P<0.05). Therefore, an increased NLR predicts survival, even in patients with recurrent breast cancer, and the NLR is potentially useful as an inflammation marker for TN breast cancer.
View Figures
View References

Related Articles

Journal Cover

February 2017
Volume 6 Issue 2

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Iwase, T., Sangai, T., Sakakibara, M., Sakakibara, J., Ishigami, E., Hayama, S. ... Nagashima, T. (2017). An increased neutrophil-to-lymphocyte ratio predicts poorer survival following recurrence for patients with breast cancer. Molecular and Clinical Oncology, 6, 266-270. https://doi.org/10.3892/mco.2016.1101
MLA
Iwase, T., Sangai, T., Sakakibara, M., Sakakibara, J., Ishigami, E., Hayama, S., Nakagawa, A., Masuda, T., Tabe, S., Nagashima, T."An increased neutrophil-to-lymphocyte ratio predicts poorer survival following recurrence for patients with breast cancer". Molecular and Clinical Oncology 6.2 (2017): 266-270.
Chicago
Iwase, T., Sangai, T., Sakakibara, M., Sakakibara, J., Ishigami, E., Hayama, S., Nakagawa, A., Masuda, T., Tabe, S., Nagashima, T."An increased neutrophil-to-lymphocyte ratio predicts poorer survival following recurrence for patients with breast cancer". Molecular and Clinical Oncology 6, no. 2 (2017): 266-270. https://doi.org/10.3892/mco.2016.1101